Mar 14, 20235 min read

Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met

First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years...

2,356 views

May 5, 20202 min read

Acesion Pharma Strengthens Clinical Team with Key Appointments

Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac...

391 views

Mar 12, 20192 min read

Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...

193 views